Supplemental material
Future Oncology
Volume 19, 2023 - Issue 1
Clinical Trial Protocol
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma
Barry Paul1 Levine Cancer Institute,Department of Hematologic Oncology and Blood Disorders,Charlotte,NC 28204,USACorrespondence[email protected]
https://orcid.org/0000-0003-2702-8225
https://orcid.org/0000-0003-2702-8225, Michaela Liedtke2 Stanford Cancer Institute,Stanford Comprehensive Cancer Center,Stanford,CA94305,USAhttps://orcid.org/0000-0001-8945-5850
https://orcid.org/0000-0001-8945-5850, Jack Khouri3 Taussig Cancer Institute,Cleveland Clinic,Department of Hematology and Medical Oncology,Cleveland,OH 44195,USAhttps://orcid.org/0000-0002-2473-6528
https://orcid.org/0000-0002-2473-6528, Robert Rifkin4 Rocky Mountain Cancer Centers,US Oncology Research,Denver,CO 80218,USAhttps://orcid.org/0000-0003-3141-1518
https://orcid.org/0000-0003-3141-1518, Mitul D Gandhi5 Virginia Cancer Specialists,Gainesville,VA 20155,USAhttps://orcid.org/0000-0002-3263-2374
https://orcid.org/0000-0002-3263-2374, , , Rebecca Silbermann8 Oregon Health & Science University,Division of Hematology/Medical Oncology,Portland,OR 97239,USAhttps://orcid.org/0000-0002-7571-1523
https://orcid.org/0000-0002-7571-1523, Francesca Cottini9 The Ohio State University Comprehensive Cancer Center,Department of Internal Medicine,Columbus,OH 43210,USAhttps://orcid.org/0000-0001-8676-7840
https://orcid.org/0000-0001-8676-7840, Douglas W Sborov10 Huntsman Cancer Institute,University of Utah,Department of Internal Medicine,Salt Lake City,UT 84112,USAhttps://orcid.org/0000-0003-4268-2698
https://orcid.org/0000-0003-4268-2698, Irwindeep Sandhu11 Cross Cancer Institute,University of Alberta,Department of Oncology,Edmonton,Alberta,T6G 1Z2,Canadahttps://orcid.org/0000-0001-9407-6265
https://orcid.org/0000-0001-9407-6265, , Michael Murphy12 Gilead Sciences, Inc,Foster City,CA 94404,USAhttps://orcid.org/0000-0001-6529-6824
https://orcid.org/0000-0001-6529-6824, Lin Gu12 Gilead Sciences, Inc,Foster City,CA 94404,USAhttps://orcid.org/0000-0003-4593-8572
https://orcid.org/0000-0003-4593-8572, , Nishanthan Rajakumaraswamy12 Gilead Sciences, Inc,Foster City,CA 94404,USAhttps://orcid.org/0000-0002-0226-0637
https://orcid.org/0000-0002-0226-0637 & Saad Z Usmani13 Memorial Sloan Kettering Cancer Center,New York City,NY 10065,USAhttps://orcid.org/0000-0002-5484-8731
https://orcid.org/0000-0002-5484-8731 show all